NCT05914662
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
Waldenstrom Macroglobulinemia
Explore clinical trials studying Waldenstrom Macroglobulinemia. Study availability and eligibility vary by location and protocol.
108 public trials
22 recruiting studies
Waldenstrom Macroglobulinemia trial results
NCT04061512
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Royal United Hospital, Bath Bath, United Kingdom
- The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust Bournemouth, United Kingdom
- East Kent Hospitals University NHS Foundation Trust Canterbury, United Kingdom
- University Hospital of Wales Cardiff, United Kingdom
Not yet recruiting
Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER)
NCT07548450
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States
Not yet recruiting
Evaluation of Iopofosine I 131 vs. R-CD in WM Patients
NCT07766421
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
Not specified
Not yet recruiting
Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy
NCT07711327
- Conditions
- Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation (AF), +35 more
- Locations
-
- City of Hope Duarte, California, United States
- UC San Diego Health San Diego, California, United States
- Stanford Health Care Stanford, California, United States
Not yet recruiting
Nemtabrutinib, Bortezomib, and Rituximab for WM
NCT07464210
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
Not yet recruiting
Study Evaluating the Efficacy and Tolerance of a Zanubrutinib and BGB-11417 Combination in Patients Previously Treated for Waldenström Macroglobulinemia
NCT06547866
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- AMIENS - CH Amiens Picardie Site Sud Amiens, France
- Angers Chu Angers, France
- ANNECY - CH Annecy Genevois Annecy, France
- ARGENTEUIL - Centre hospitalier Victor Dupouy Argenteuil, France
Not yet recruiting
Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies
NCT04702932
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Service de Médecine Interne Paris, France
Active, not recruiting
Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
NCT00039676
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- NIH National Cancer Institute - Shady Grove Rockville, Maryland, United States
Active, not recruiting
Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
NCT07387471
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital /ID# 279178 Nagoya, Aichi-ken, Japan
- Nagoya City University Hospital /ID# 277580 Nagoya, Aichi-ken, Japan
- University of Fukui Hospital /ID# 279173 Yoshida-gun, Fukui, Japan
- Kyushu University Hospital /ID# 277582 Fukuoka, Japan